Episodes
-
A new NAMS study officially names perimenopause uncertainty as a clinically distinct and widespread experience — and explains why so many women feel dismissed or confused before they ever get a diagnosis. This episode also covers a promising randomized trial on compassionate mind training for menopause-related mood and anxiety, and takes a hard look at what "shows promise" actually means when a supplement brand uses it in a headline.Key Takeaways:• Perimenopause uncertainty — not knowing whether your symptoms are perimenopause or something else — is now recognized in peer-reviewed research as a clinically meaningful phenomenon, distinct from illness-related uncertainty.• The uncertainty isn't just uncomfortable; it delays validation, delays care, and has real mental health consequences for women in the transition.• Compassionate Mind Training (CMT), a structured group intervention rooted in self-compassion and emotion regulation, showed feasibility and early signal for reducing anxiety and low mood in a randomized controlled trial — though a fully powered effectiveness trial still needs to happen.• Elysium's NR-based supplement generated a headline claiming it "shows promise" for menopause symptoms — but the source is NutraIngredients, a trade publication, not a peer-reviewed journal, and no independent trial data was available at time of publishing.• For mood and anxiety specifically, non-hormonal, evidence-adjacent options like CMT are worth watching — particularly for women who can't or don't want to use HRT.Sources & References:• Perimenopause uncertainty prevalence and drivers: a mixed-methods study (https://pubmed.ncbi.nlm.nih.gov/42445976/) - Menopause (NAMS Journal)• Compassionate mind training for low mood and anxiety in the menopause transition: a feasibility RCT (https://pubmed.ncbi.nlm.nih.gov/42412587/) - Menopause (NAMS Journal)• Elysium's supplement shows promise for menopause symptoms (https://news.google.com/rss/articles/CBMiqwFBVV95cUxOM1FUajFEUktpXzkwSXZReDVkcHVGQ2YwZ1gyVnZjX2ZHMzdkWnVPVjlSQ1p1UXYyMDN4ZnV4S2dHcXhxVUpsOVVnLTZfUDQwZWhiSEFlNUFCdG5XdGp2dzJZRHhQUlZwLXcwdWpVSGhiRG9hS29SLWZvV016emt2VjNkalIwN2xxWVhSSi0yRE51WnFGM0tpUFhoRXJWN05fMVJ5RzlfRnZsVVE) - NutraIngredients.comListen with full show notes: https://hotflasher.com/episodes/2026-07-24-listener-storyHave a menopause story to share? We'd love to hear it:https://hotflasher.com/share---Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
-
This episode covers the systemic gaps in menopause diagnosis and treatment, anchored by Melinda French Gates's account of needing three doctors to identify her perimenopause, new Medscape data showing Medicaid patients are half as likely to receive menopause medications, and a NHANES study linking social disadvantage to earlier reproductive aging.
Key Takeaways:
• Melinda French Gates, with full access to elite medical care, still required three separate doctors before receiving a perimenopause diagnosis — illustrating how common diagnostic failure is in menopause care.
• Medicaid patients are approximately half as likely to receive menopause medications compared to privately insured patients, according to new Medscape reporting.
• A NHANES analysis spanning 1999–2018 found that cumulative social disadvantage — including food insecurity, housing instability, lower education, and lower income — is associated with a shorter reproductive lifespan.
• Food security, housing status, education level, and income were all identified as significant individual contributors to earlier reproductive aging, suggesting menopause timing is partly shaped by social conditions, not just biology.
• These three data points together describe a system where the women most likely to need support accessing menopause care are also the women most likely to enter menopause earlier and least likely to receive treatment for it.
Sources & References:
• Melinda French Gates on perimenopause: "It took me 3 doctors to really diagnose what I was going through" (https://news.google.com/rss/articles/CBMiigFBVV95cUxNU1pycko4bS14emR3dG9NekRMMnpsblJCdnlUOTM4YlVNdWR0OHRRRzNaZVpzbEQ2TkRaemthTW8xMlBlaXJnd2RlM09Hd3Z2d2RndVI1YkNRMTd0bUZrdHk4LW5zd2lnUFNnOWFOOHA5QUloaFNYRWExZWpnaDBGc21kS1VpNjlfT0E) - CBS News
• Medicaid Patients Half as Likely to Get Menopause Meds (https://news.google.com/rss/articles/CBMipgFBVV95cUxPckRCRGI5ZmM0VUtIeU9uRzhyc2VQOTBtcF9wUGtyZGJWSE40X096c1o2d3pod2Q3ZHVic1JzVDI0aVZYWXNYZWd6bXpHaklEYTNUaWUtLWF5V3pDdFo1dTM0MU1lb1NUYjBDS1l4dHFLdWl5OFBFdG5CZDFaQlJJRzNabHdmWXhqaUw3R09hcmRiUkZBWGJienhEYWRtUWFrQnJWMHZR) - Medscape
• Cumulative social determinants of health and reproductive lifespan among US women: NHANES 1999–2018 analysis (https://pubmed.ncbi.nlm.nih.gov/42445967/) - Menopause (NAMS Journal)
Listen with full show notes: https://hotflasher.com/episodes/2026-07-23-influencer-roundup
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns. -
Episodes manquant?
-
This episode covers three new studies published July 21, 2026: one on how women with limited incomes in China understand and practice bone health, one on the under-researched link between sleep apnea and overactive bladder in women, and one on smoking's relationship to breast density and cancer risk in Asian women. Nykki looks at what each one tells us — and what the research is still missing.
Key Takeaways:
• Many women aged 40–65 with limited income in China scored low on bone health *practices* even when awareness was moderate, pointing to a knowledge-to-action gap that isn't unique to any one country.
• Obstructive sleep apnea is significantly underdiagnosed in women, and a 2026 narrative review found a meaningful association between OSA and overactive bladder symptoms — a connection that has been studied almost exclusively in male populations until recently.
• Women with sleep apnea who are waking at night to urinate may be experiencing a physiological chain reaction tied to disrupted breathing, not just an isolated bladder issue.
• The smoking and breast density study found that current smokers showed different breast density patterns compared to non-smokers, with implications for mammography sensitivity and cancer risk interpretation in Asian women.
• All three studies share a design limitation worth noting: none of them establish causation, and two are population-specific in ways that limit how far you can generalize the findings.
Sources & References:
• Bone health attitudes and practices in women aged 40–65 with limited income in China (https://pubmed.ncbi.nlm.nih.gov/42480103/) - PubMed
• Obstructive sleep apnea and overactive bladder: expanding the perspective to women (https://pubmed.ncbi.nlm.nih.gov/42479276/) - PubMed
• Smoking habits, breast density changes, and breast cancer risk in Asian women (https://pubmed.ncbi.nlm.nih.gov/42479205/) - PubMed
Listen with full show notes: https://hotflasher.com/episodes/2026-07-22-myth-busting
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns. -
This episode goes deep on three underrecognized menopause symptoms: a decade-long review of pain across the transition, new diagnostic criteria for nighttime frequent urination, and a feasibility trial testing compassionate mind training for mood and anxiety. All three studies come from the NAMS journal and were published in July 2026.
Key Takeaways:
• Menopause-associated pain is not one thing — it spans joint pain, headaches, genitourinary pain, and more, each with different hormonal and psychosocial drivers, and a decade of research still hasn't produced a unified clinical framework for managing it.
• Nighttime frequent urination (nocturnal polyuria) is a legitimate menopause symptom, but current diagnostic thresholds were built without adequately accounting for aging female physiology — a new framework proposes anchoring diagnosis to a nocturnal polyuria index of 28% plus symptom bother, which better reflects menopausal women's actual experience.
• A small randomized feasibility trial found compassionate mind training — a structured group program rooted in self-compassion — was acceptable and feasible for women with menopause-related low mood and anxiety, with promising signals on mental health outcomes, though a fully powered trial is still needed.
• The pain review specifically flags that psychosocial context — stress, sleep disruption, history of depression — amplifies menopause pain, which means treating it as purely hormonal will miss a significant part of what's driving it.
• All three studies are in the same NAMS journal issue, and the collective gap they point to is the same: symptoms that real women are living with don't yet have the clinical infrastructure to be properly diagnosed and treated.
Sources & References:
• Menopause-associated pain: a decade review of patterns, determinants, and research priorities (https://pubmed.ncbi.nlm.nih.gov/42412599/) - Menopause (NAMS Journal)
• Derivation and validation of a symptom-anchored diagnostic criterion for nocturnal polyuria in women (https://pubmed.ncbi.nlm.nih.gov/42413021/) - Menopause (NAMS Journal)
• Group-based compassionate mind training for low mood and anxiety in the menopause transition: a feasibility RCT (https://pubmed.ncbi.nlm.nih.gov/42412587/) - Menopause (NAMS Journal)
Listen with full show notes: https://hotflasher.com/episodes/2026-07-21-symptom-spotlight
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns. -
This episode covers three research stories from July 2026: a new meta-analysis confirming resistance training's cardiovascular benefits for postmenopausal women, a large NHANES study linking social disadvantage to earlier menopause onset, and a Nature piece calling out England's Women's Health Strategy for ignoring dental health in 13 million menopausal women. Nykki takes positions on what the evidence actually supports, what the systemic failures look like, and why menopause timing isn't just biology.
Key Takeaways:
• A 2026 systematic review and meta-analysis found resistance training improves cardiovascular health markers in postmenopausal women — adding to a growing body of evidence that lifting is genuinely protective, not just aesthetic.
• A NHANES analysis of US women from 1999–2018 found that cumulative social disadvantage — including food insecurity, housing instability, lower education, and lower income — was associated with a shorter reproductive lifespan, meaning earlier menopause.
• Food security, housing status, education level, and income-to-poverty ratio were the strongest individual contributors within that social determinants mix.
• A Nature-published commentary found that England's Women's Health Strategy makes no provision for the dental health of menopausal women, despite estrogen loss having well-documented effects on gum tissue, bone density in the jaw, and saliva production.
• Menopause timing is not a purely biological event — where and how you live appears to shape when it happens, which has downstream implications for cardiovascular risk, bone density, and cognitive health.
Sources & References:
• Resistance Training Improves Cardiovascular Health in Postmenopausal Women: Systematic Review and Meta-Analysis (https://pubmed.ncbi.nlm.nih.gov/42470140/) - PubMed
• Cumulative social determinants of health and reproductive lifespan among US women: a NHANES 1999-2018 analysis (https://pubmed.ncbi.nlm.nih.gov/42445967/) - Menopause (NAMS Journal)
• Women's Health Strategy overlooks 13 million menopausal women's dental health (https://news.google.com/rss/articles/CBMiXkFVX3lxTE00UWsyTnQyV04xbVgycjB5XzFrOHBRMHpfb2MzWHhGSVQ3RlhrZEpWZE1IbzZFMDU2WHFfR2R1ZFlOeFJ4bWlqcUQ0b0h1N0V5aFlmczNiLWo5SEZzZFE?oc=5) - Nature / Google News
Listen with full show notes: https://hotflasher.com/episodes/2026-07-20-research-roundup
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns. -
This episode covers three new studies published this week touching on women's health at midlife and beyond. Nykki looks at how neighborhood-level factors shape cardiovascular risk in midlife women, a major international consensus statement on pregnancy- and lactation-associated osteoporosis, and new longitudinal data on whether calcium supplements actually move the needle when you're already on bone-building medication.
Key Takeaways:
• A new study links neighborhood vulnerability — factors like poverty, lack of green space, and pollution exposure — to worse cardiovascular health in midlife women, independent of individual health behaviors.
• Six international bone health organizations released a joint position statement on pregnancy- and lactation-associated osteoporosis (PLO), a rare but serious condition that is frequently missed or misdiagnosed because clinicians aren't trained to look for it.
• A longitudinal observational study found that among older women already on antiresorptive osteoporosis treatment, additional calcium supplementation did not consistently produce better bone outcomes — dietary calcium intake may matter more than supplements.
• The cardiovascular findings suggest that individual lifestyle advice is not sufficient when the environment itself is working against you — a public health problem that individual behavior change cannot solve.
• For women with a history of pregnancy- or breastfeeding-related bone loss, the new PLO consensus statement is worth bringing to a clinician, as standardized guidance has previously been lacking.
Sources & References:
• Sociodemographic and neighborhood vulnerability linked to cardiovascular health in midlife women (https://pubmed.ncbi.nlm.nih.gov/42464805/) - PubMed
• Pregnancy- and lactation-associated osteoporosis: joint position statement from IAPM, IOF, ECTS, ESCEO, IMS, and EMAS (https://pubmed.ncbi.nlm.nih.gov/42464584/) - PubMed
• Dietary vs. supplemental calcium during antiresorptive osteoporosis treatment in older women (https://pubmed.ncbi.nlm.nih.gov/42463975/) - PubMed
Listen with full show notes: https://hotflasher.com/episodes/2026-07-17-listener-story
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns. -
A new study published in the NAMS journal Menopause links premature menopause to significantly higher risk of kidney stone disease across two large datasets, including the UK Biobank. Scotland has approved the first non-hormonal menopause drug, expanding options for women who can't or won't use hormone therapy. And Washington State's governor has signed an executive order requiring workplace support for employees experiencing perimenopause and menopause.
Key Takeaways:
• Women who experienced premature menopause (before age 40) showed a consistently higher risk of kidney stone disease across both UK Biobank and NHANES cohorts, with the association holding up across multiple analytical methods.
• Hormone therapy did not meaningfully modify the kidney stone risk, suggesting the connection may be driven by genetic or metabolic factors rather than estrogen loss alone.
• Scotland has approved a non-hormonal drug for menopause symptoms — significant news for the substantial number of women who cannot use or choose not to use HRT.
• Washington Governor Bob Ferguson signed an executive order directing state agencies to support employees experiencing perimenopause and menopause in the workplace, making Washington one of the more concrete US policy actors on this issue.
• The kidney stone–premature menopause link is a reminder that early menopause has downstream health consequences beyond the cardiovascular and bone density risks that get most of the attention.
Sources & References:
• Premature menopause and risk of kidney stone disease: UK Biobank and NHANES evidence (https://pubmed.ncbi.nlm.nih.gov/42445973/) - Menopause (NAMS Journal)
• First non-hormonal menopause drug approved in Scotland (https://news.google.com/rss/articles/CBMiowFBVV95cUxOSnY1VGIxdzdROF9KbjNhc09SbFBXQWpNa2ZCS1FMTWtyY0gzbFg3Tm1SOEE1SjRTZUdOSHBJMktkSVlJSEk1ZVRvVGVVejFxaThlQmt4aWh5ZUJZeXVKWGFRNnYyNDk5clhoSC1oLVNtTExVSmtCcmNhbFFOUG11VG9XTy1JbkRhbUI0NjBhVlQ0ME1xNWpJNEZoQ0c5b09sTmJ3?oc=5) - Medscape via Google News
• Governor Ferguson signs Executive Order supporting women experiencing perimenopause and menopause in the workplace (https://news.google.com/rss/articles/CBMixwFBVV95cUxNdkFQMEtfUUp1QVpITmdaR0ljbVFnUWg3MFlYclprbTdfa2RMWjNIOU5aTWRSOFhJYU1TMXFfNnhkNUFjWWhOeHZSM19ER3JKYlEtN1pYbjF2YVdXeXJuR3dLR0dvN1QxVjVzTGFlSXdrMTQyelRXV1ppZUFFSzJybXJfVm82OUZUdWw1cjBIMHY1cEtvOWxHMEIxZmlDT1V0TUVVV1JZM1h5S216amZSQ2djSnlhcGloTHotcHJicDhORkQwSzNJ?oc=5) - Governor Bob Ferguson (.gov) via Google News
Listen with full show notes: https://hotflasher.com/episodes/2026-07-16-influencer-roundup
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns. -
A new study used Reddit posts to map menopause symptoms that consistently go undocumented in clinical records — and the gap is significant. Scotland has approved fezolinetant (Veoza), the first non-hormonal drug specifically licensed for menopause symptoms. And a 2026 PubMed study found that air pollution — specifically nitrogen oxide and sulfur dioxide — accelerates bone loss in postmenopausal women, with social determinants shaping who bears the most risk.Key Takeaways:• Reddit data revealed a wider range of menopause symptoms than what appears in clinical medical records, suggesting clinical documentation consistently undercaptures what women actually experience.• Scotland has approved fezolinetant (brand name Veoza), a neurokinin 3 receptor antagonist, as the first non-hormonal prescription option specifically licensed for menopause vasomotor symptoms.• A 2026 study published in PubMed found that nitrogen oxide and sulfur dioxide exposure is associated with measurable bone damage in postmenopausal women in the United States.• The air pollution–bone loss connection is shaped by social determinants — women with lower income and less access to resources face disproportionately higher risk from the same pollution levels.• Bone loss after menopause is not purely hormonal; environmental exposures and social circumstances are factors the standard clinical conversation almost never includes.Sources & References:• Reddit exposes menopause symptoms often missing from medical records (https://news.google.com/rss/articles/CBMitwFBVV95cUxOYjV6QmVBTjkzRl95S1NsbTJ5ajlseWltYlExZWlvSDhHTG1iT3dpSmZoWFEtWDJ0N1hGS0d5ODBkTURSOTN0d2JfcmdyMVB3NVBPUmhsX242R3VRZzRrRjBzbDlrZkk2ZjdSaE1JUjdYMGF0LV9FQmdRaFlUY1habHZEZUtnMGtWYTEwUlo1NUtTQm9zLVRkX0lWQzQyWm1kOWIxQ21rb1gxdzhlU21sT2JfQzNwWm8?oc=5) - News-Medical• First Non-Hormonal Menopause Drug Approved in Scotland (https://news.google.com/rss/articles/CBMiowFBVV95cUxPSnY1VGIxdzdROF9KbjNhc09SbFBXQWpNa2ZCS1FMTWtyY0gzbFg3Tm1SOEE1SjRTZUdOSHBJMktkSVlJSEk1ZVRvVGVVejFxaThlQmt4aWh5ZUJZeXVKWGFRNnYyNDk5clhoSC1oLVNtTExVSmtCcmNhbFFOUG11VG9XTy1JbkRhbUI0NjBhVlQ0ME1xNWpJNEZoQ0c1b09sTmJ3?oc=5) - Medscape• Social determinants of vulnerability to nitrogen oxide- and sulfur dioxide-related bone damage among postmenopausal women in the United States (https://pubmed.ncbi.nlm.nih.gov/42454308/) - PubMedListen with full show notes: https://hotflasher.com/episodes/2026-07-15-myth-bustingHave a menopause story to share? We'd love to hear it:https://hotflasher.com/share---Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
-
This episode digs into a new study linking subclinical cartilage degradation to bone density and trace element levels in women with osteopenia and osteoporosis — and why the "subclinical" part matters most. Nykki also looks at a PubMed review on menopause apps and the gap between what they promise and what the evidence supports, plus a fertility-window study with implications that extend well into perimenopause.Key Takeaways:• Cartilage degradation in women with osteopenia and osteoporosis may be measurable before symptoms appear, suggesting bone and joint protection strategies may need to start earlier than most women are told.• Trace elements — including zinc and selenium — showed associations with cartilage and bone health in postmenopausal women in the Abbood et al. study, though the research is observational and can't establish cause.• A 2026 PubMed review found menopause apps vary widely in clinical accuracy; some provide useful symptom tracking, but others make claims that outrun the evidence behind them.• Urine hormone monitoring for fertile window modeling (Bouchard et al.) shows meaningful hormonal variability across the reproductive lifespan — which has direct relevance for perimenopausal women still trying to understand their cycles.• Symptom-tracking apps are most useful as a conversation starter with a clinician, not as a substitute for one.Sources & References:• Menopause apps offer empowerment but pose risks (https://pubmed.ncbi.nlm.nih.gov/42444043/) - PubMed• Modeling fertile window differences across the reproductive lifespan with urine hormone monitoring (https://pubmed.ncbi.nlm.nih.gov/42443950/) - PubMed• Subclinical cartilage degradation, bone density, and trace elements in peri- and postmenopausal women with osteopenia and osteoporosis (https://pubmed.ncbi.nlm.nih.gov/42442971/) - PubMedListen with full show notes: https://hotflasher.com/episodes/2026-07-14-symptom-spotlightHave a menopause story to share? We'd love to hear it:https://hotflasher.com/share---Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
-
This episode covers three new papers published July 2026: a systematic review examining HRT safety across women with common health conditions, a methodological critique of how brain-menopause research gets interpreted, and a head-to-head exercise study testing whether intensity level matters for postmenopausal cardiovascular health. Research credibility is the through-line — all three papers are worth understanding on their own terms, not just their headlines.
Key Takeaways:
• A new 2026 systematic review suggests HRT risk-benefit calculations look different depending on specific comorbidities — cardiovascular disease, diabetes, and osteoporosis each carry distinct considerations, and blanket avoidance is not supported across the board.
• A published response paper challenges how cross-sectional study designs are being used to draw conclusions about menopause and brain health — the limitation is about causality, not about whether the brain-menopause connection is real.
• A 2026 RCT found that higher-intensity aerobic exercise produced meaningfully better improvements in cardiorespiratory fitness and cardiometabolic markers in postmenopausal women compared to lower-intensity protocols.
• Cross-sectional brain imaging studies can tell us which brain features correlate with menopausal status, but they cannot tell us whether menopause caused those features — that distinction matters for how we interpret the research.
• The exercise intensity finding matters practically: moderate-effort walking is not equivalent to vigorous aerobic work when it comes to cardiovascular outcomes in this population.
Sources & References:
• Systematic review: hormone replacement therapy in postmenopausal women with medical co-morbidities (https://pubmed.ncbi.nlm.nih.gov/42439012/) - PubMed
• Response to interpreting cross-sectional comparisons of menopausal status and brain outcomes (https://pubmed.ncbi.nlm.nih.gov/42438864/) - PubMed
• Comparative effects of aerobic exercise intensity on cardiorespiratory fitness and cardiometabolic risk in postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42438853/) - PubMed
Listen with full show notes: https://hotflasher.com/episodes/2026-07-13-research-roundup
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns. -
A 2026 study links adverse childhood experiences to earlier menopause onset and higher dementia risk — and the biological pathway is more direct than you might expect. This episode also covers why bladder symptoms in menopause keep getting misdiagnosed and undertreated, and a concerning finding about how uterine fibroids can mask endometrial cancer on ultrasound.
Key Takeaways:
• Women with higher ACE scores had greater rates of early menopause, and early menopause is itself associated with elevated dementia risk — suggesting childhood trauma may set off a chain with long-term cognitive consequences.
• Urinary symptoms like urgency, frequency, and recurrent UTIs are often manifestations of genitourinary syndrome of menopause (GSM), not separate conditions — and they respond to estrogen-based treatments that most women are never offered.
• A retrospective cohort study found that uterine fibroids significantly reduce ultrasound's ability to detect both endometrioid and serous endometrial cancers, meaning women with fibroids may need additional or alternative imaging if endometrial cancer is a concern.
• GSM affects an estimated 50-70% of postmenopausal women but remains dramatically underdiagnosed, in part because clinicians don't ask and patients don't connect the symptoms to menopause.
• The fibroid-ultrasound finding is particularly consequential for serous endometrial cancer, which is the more aggressive subtype — a missed or delayed diagnosis carries serious stakes.
Sources & References:
• Adverse childhood experiences, early menopause, cognition, and dementia risk in older U.S. adults (https://pubmed.ncbi.nlm.nih.gov/42428989/) - PubMed
• Urinary manifestations of genitourinary syndrome of menopause: pathophysiology, presentation, and management (https://pubmed.ncbi.nlm.nih.gov/42428460/) - PubMed
• Uterine fibroids reduce ultrasound sensitivity for detecting endometrial cancer: retrospective cohort study (https://pubmed.ncbi.nlm.nih.gov/42428452/) - PubMed
Listen with full show notes: https://hotflasher.com/episodes/2026-07-10-listener-story
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns. -
This episode covers three new research items: a 2026 study on how physical activity protects against dementia differently depending on menopausal status, a NAMS journal paper on the largely invisible menopause experience of women with criminal legal system involvement, and fresh WHI clinical trial data on HRT, migraine history, and headache severity.
Key Takeaways:
• A July 2026 study (Lim et al.) found that physical activity's protective effect against dementia varies by menopausal status — suggesting timing relative to menopause may matter, not just the activity itself.
• Women with criminal legal system involvement commonly experience menopausal symptoms, some of them severe, while facing institutional barriers that make accessing care significantly harder than the general population.
• New analysis of WHI hormone therapy trial data found associations between menopausal hormone therapy, migraine history, and headache severity — relevant for the large overlap between migraine sufferers and perimenopausal women.
• The menopause research landscape still skews heavily toward women with stable housing, healthcare access, and no legal-system involvement — a blind spot with real clinical consequences.
• On HRT and migraines: if you have a migraine history and are considering or currently using hormone therapy, this is a conversation to have with your doctor — not a reason to panic, but a data point that matters.
Sources & References:
• Role of Physical Activity in Protecting Against Dementia According to Menopausal Status (https://pubmed.ncbi.nlm.nih.gov/42421403/) - PubMed
• Menopause experience among people with criminal legal system involvement (https://pubmed.ncbi.nlm.nih.gov/42412584/) - Menopause (NAMS Journal)
• Menopausal hormone therapy, migraine history, and headache severity: Results from the Women's Health Initiative Hormone Therapy clinical trials (https://pubmed.ncbi.nlm.nih.gov/42419355/) - PubMed
Listen with full show notes: https://hotflasher.com/episodes/2026-07-09-influencer-roundup
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns. -
This episode covers three new studies: a 2026 trial on a rhubarb root extract for perimenopausal migraines, a Chinese study linking a metric called the Cardiometabolic Index to coronary artery disease severity in menopausal women, and a case report on appendix endometriosis that doubles as a reminder of how badly the medical system underestimates this disease. Research credibility lens throughout, with a hard take on the endometriosis case and what it says about diagnostic culture.Key Takeaways:• ERr 731, a standardized extract from rhubarb root, showed statistically significant reductions in headache and migraine frequency in perimenopausal women in a 2026 study — but the trial is small and the funding source warrants scrutiny before drawing strong conclusions.• The Cardiometabolic Index (CMI) — a ratio derived from waist circumference, height, and blood triglycerides — correlated with both the presence and severity of coronary artery disease in a study of menopausal women, and may be a more accessible screening signal than some current clinical tools.• Endometriosis can occur in the appendix, and when it does, it can present as acute appendicitis — the 2026 case report involved a postmenopausal woman, a reminder that endometriosis does not reliably stop at menopause.• Appendix endometriosis is almost never diagnosed before surgery; the diagnosis is typically made by pathology after the appendix is removed.• The endometriosis case highlights a persistent gap: when women present with acute abdominal pain, endometriosis often isn't on the differential — and that's a clinical culture problem, not just a knowledge gap.Sources & References:• ERr 731 rhubarb extract: efficacy for migraine and perimenopausal symptoms (https://pubmed.ncbi.nlm.nih.gov/42416823/) - PubMed• Cardiometabolic Index and coronary artery disease severity in menopausal women (https://pubmed.ncbi.nlm.nih.gov/42416596/) - PubMed• Endometriosis of the vermiform appendix: case report and literature review (https://pubmed.ncbi.nlm.nih.gov/42416415/) - PubMedListen with full show notes: https://hotflasher.com/episodes/2026-07-08-myth-bustingHave a menopause story to share? We'd love to hear it:https://hotflasher.com/share---Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
-
This episode covers three findings reshaping how we understand menopause and perimenopause: new research suggesting postmenopausal ovaries undergo a cellular identity shift that may fuel chronic inflammation, a lesser-known perimenopause symptom that has women alarmed after Penélope Cruz and Olivia Wilde discussed it publicly, and a study linking lifelong exposure to violence with significantly earlier menopause onset.Key Takeaways:• New research suggests that after menopause, ovaries don't simply become inactive — they may undergo a cellular identity shift that contributes to chronic inflammation, potentially explaining joint pain and fatigue that get dismissed as "just aging."• Penélope Cruz and Olivia Wilde both publicly discussed electric shock sensations — a perimenopause symptom called dysesthesia — sending many women to search for something they'd never been warned about.• A study found that women who experienced lifelong violence had significantly earlier menopause onset, suggesting cumulative trauma exposure has measurable physiological effects on reproductive aging.• The ovary inflammation finding is early-stage research; it hasn't yet established a direct causal chain from cellular identity shift to specific symptoms, which means it warrants attention but not alarm.• The violence-menopause link adds to a growing body of evidence that chronic stress and trauma accelerate biological aging in women — a factor rarely addressed in standard menopause care.Sources & References:• Ovary identity shift after menopause may contribute to inflammation (https://news.google.com/rss/articles/CBMiswFBVV95cUxQMzlwNUd0bWg0Wm5QeGpoNWpYUDhocDJYb056Y3VfU3lxSF9xUEsyZnM1bGlWUDBCLWNDMFNEazFXR0lOQzZhaV9rOGJ3ckhFSmFUYVBHbVgxQlFDQXc0ZkFwd2ZwR1BZZzlxdC1sTmpjS040d3NMLVlkUkQzbDVJUGxwMDZfWUV0WTdXOGw4MkJhcmJOZDJQMnBYUkIwcXk5WHZxYURuQmhONWUySTJFQlkwQQ) - New Scientist• Women are "petrified" after Penélope Cruz and Olivia Wilde discussed a perimenopause symptom they had no idea existed (https://news.google.com/rss/articles/CBMingFBVV95cUxPa3lQNXozdklhaU1RYU1Ub1lmOHdTTWd5dWhLdHg5N1RZZEFsTTdnRzhCcXh2b3k0QmdhR3FFUFMxanFReW04cGc0WmN0TXh0bTJzU3A4SkFkd2ZEanl0UGhnZmNobGtVaVBjdl9TRndybE95NjQyWGZHSHZBeDIweGxrSk5CTmVCVVBjZUc0UW1HSFlTdXFCVFRwWHp1Zw) - BuzzFeed• Lifelong violence against women linked to significantly earlier menopause onset (https://news.google.com/rss/articles/CBMivgFBVV95cUxNRnRLVHh1cTJRZkVkQUY4Rkxad0RYUl9udG1sVFB1Q0luLXdFb3N1NFRPN1laYmFkU0JQWmU2b2hOOGdmZFMtb2sxRWVpNnRRQ2FCMVdwdlJPQzNfOEVNVmw3bE9xUlFOLWxoZzg3RDFzak5mVHpkUmRXekp5emtfUHdVal84QmNGaEJOYXNXbEY3NFVDc2pvODhnRThNejJHbEs5ODZXUVhlQ1lRalpudHc5VjhZcUszclRNRzFR) - News-MedicalListen with full show notes: https://hotflasher.com/episodes/2026-07-07-symptom-spotlightHave a menopause story to share? We'd love to hear it:https://hotflasher.com/share---Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
-
This episode covers three recent research items: a case study linking electroconvulsive therapy to a stress-induced heart condition more common in women, a quasi-experimental trial on Nordic walking and strength training for postmenopausal metabolic markers, and early-stage lab research on a plant compound that may protect bone in diabetic osteoporosis. Nykki reads into what each piece of research actually shows — and what it doesn't.
Key Takeaways:
• Takotsubo cardiomyopathy (stress cardiomyopathy) affects women at disproportionately higher rates than men, and a 2026 case study flags ECT as a potential trigger — a connection worth knowing if ECT is on the table for perimenopausal depression.
• A 2026 quasi-experimental study found that high-intensity interval Nordic walking combined with strength training improved multiple metabolic syndrome biomarkers in postmenopausal women with abdominal obesity — but the study design can't establish cause and effect on its own.
• β-Caryophyllene, a compound naturally present in black pepper and cloves, showed bone-protective effects in a diabetic osteoporosis model by blocking ferroptosis through the AMPK/Nrf2 pathway — this is preclinical research, not a supplement recommendation.
• The ferroptosis pathway is an emerging area of bone research that may eventually open new therapeutic targets for osteoporosis, particularly in women with comorbid diabetes.
• Nordic walking — walking with poles that engage the upper body — may have a metabolic edge over regular walking, though larger randomized trials are needed before drawing firm conclusions.
Sources & References:
• Electroconvulsive therapy as a trigger for Takotsubo cardiomyopathy (https://pubmed.ncbi.nlm.nih.gov/42405377/) - PubMed
• High intensity interval Nordic walking and strength training effects on metabolic syndrome biomarkers in postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42405339/) - PubMed
• β-Caryophyllene protects against diabetic osteoporosis by blocking ferroptosis via the AMPK/Nrf2 pathway (https://pubmed.ncbi.nlm.nih.gov/42403939/) - PubMed
Listen with full show notes: https://hotflasher.com/episodes/2026-07-06-research-roundup
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns. -
This episode covers a menopause-specialist PT's five evidence-backed habits for building muscle in your 50s, a new longitudinal study on how blood pressure shifts across the menopause transition, and a secondary analysis of a clinical trial finding that a soy-supplemented vegan diet reduced severe hot flashes — regardless of how processed the plant foods were.
Key Takeaways:
• A menopause-specialist PT identifies protein intake, progressive overload, and sleep as the non-negotiables for building muscle in your 50s — not the latest supplement stack.
• A 2026 longitudinal cohort study found that blood pressure trajectories shift meaningfully across the menopause transition, with increases most pronounced in the late perimenopausal and early postmenopausal window.
• A secondary analysis of a randomized clinical trial found that replacing animal foods with plant foods on a soy-supplemented vegan diet was associated with significant weight loss and reduced severe hot flashes — whether those plant foods were minimally processed or ultra-processed.
• The hot flash finding challenges the assumption that food quality (ultra-processed vs. whole) is the main lever — swapping the animal products themselves appears to be what drove the benefit in this study.
• Blood pressure changes during menopause are often attributed to aging alone, but this study's tracking across the transition suggests the hormonal shift itself is a meaningful contributing factor worth monitoring separately.
Sources & References:
• 5 non-negotiable muscle-building habits from a menopause personal trainer (https://news.google.com/rss/articles/CBMiogFBVV95cUxOTFd6X0ZqMm1FR2tLOC1YU3FidUN5U1JFRk5CU1dQY1FzQTZxWmJwLWVPYlNUTm9LVklyeUgtZTZfOE5UWmdla3VrNjhLVkpQZFR5SC1wTmhzcC1Id3lKd2J2YnNmVExiakhYZHdQYXFUazJ6Yk1NY0UySEJuQ0tSUTJDYWYtREEtekZDSWRRR3MwWk8wMElQSkpEMWVKSzhoeHc) - Women's Health
• Trajectories of blood pressure and influencing factors across menopause: A longitudinal cohort study (https://pubmed.ncbi.nlm.nih.gov/42395099/) - PubMed
• Processed foods, vegan diet, and severe hot flashes in postmenopausal women: secondary analysis of a randomized clinical trial (https://pubmed.ncbi.nlm.nih.gov/42345553/) - Menopause (NAMS Journal)
Listen with full show notes: https://hotflasher.com/episodes/2026-07-03-listener-story
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns. -
A new JAMA study connects sarcopenia-related decline — muscle loss, slower walking pace, weaker grip — to elevated stroke risk, with direct implications for midlife women. A cross-sectional study in the NAMS journal reframes midlife sexual difficulties as a couples issue, not just a woman's problem. And a pilot study out of the Menopausia, Salud, Corazón project uses hair cortisol to explore how psychosocial stress intersects with menopause symptoms in Latina women — a demographic that's been dramatically underrepresented in this research.Key Takeaways:• A JAMA study found that muscle loss, slower walking pace, and weaker grip strength are each independently associated with higher stroke risk — not just cardiovascular disease generally, but stroke specifically.• Strength training and maintaining walking pace aren't vanity metrics or fitness goals for their own sake; for midlife women already losing muscle mass, they may carry real neurological stakes.• A cross-sectional study in the NAMS journal found that both male and female partner factors influence female sexual function in couples aged 50–70 — meaning treating low desire or painful sex as a solo problem misses half the picture.• The Menopausia, Salud, Corazón pilot study used hair cortisol — a measure of chronic stress over weeks or months, not just a single moment — to examine how psychosocial stress and menopause symptoms interact in midlife Latina women, a group rarely centered in menopause research.• Pilot studies deserve appropriate caution: small sample sizes mean we're looking at signals, not conclusions — but the direction of inquiry itself matters when a population has been historically excluded from the data.Sources & References:• Male and female factors affecting sexual function in couples aged 50–70 (https://pubmed.ncbi.nlm.nih.gov/42345552/) - Menopause (NAMS Journal)• Psychosocial stress, menopause symptoms, and hair cortisol in midlife Latinas (https://pubmed.ncbi.nlm.nih.gov/42388907/) - PubMedListen with full show notes: https://hotflasher.com/episodes/2026-07-02-influencer-roundupHave a menopause story to share? We'd love to hear it:https://hotflasher.com/share---Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
-
This episode covers three research stories that push back on conventional menopause narratives: new findings suggesting postmenopausal ovaries take on a second biological role, a grounded look at whether creatine's growing menopause popularity is actually backed by evidence, and a surprising RCT result showing that ultra-processed plant foods may still reduce hot flashes and body weight when animal products are replaced in a soy-supplemented vegan diet.Key Takeaways:• New research suggests postmenopausal ovaries don't simply switch off — they may develop a secondary biological function, which has real implications for how we think about ovary-sparing surgery decisions.• Creatine has early but genuinely promising evidence for muscle mass and bone density in postmenopausal women, though most studies are small and short-term; the brain-benefit claims are the weakest part of the current evidence base.• A secondary analysis of an RCT published in the NAMS journal found that replacing animal foods with plant foods — including ultra-processed plant foods — was associated with significant weight loss and fewer severe hot flashes, within a soy-supplemented vegan diet.• The ultra-processed finding is context-dependent: it doesn't mean a bag of Doritos is a hot flash treatment. The dietary context — specifically the soy supplementation and the overall shift away from animal products — appears to be doing the heavy lifting.• The ovary research is early-stage and mechanistic; it doesn't change clinical recommendations today, but it's the kind of finding that should make surgeons think twice before routine removal of postmenopausal ovaries during unrelated pelvic procedures.Sources & References:• Ovaries Appear to Develop an Incredible Second Role After Menopause (https://news.google.com/rss/articles/CBMinAFBVV95cUxOT2U0N1hlWGU1eVYwNUdZb3ZJYnE5U2QtTy12UThuczFrNi1hVnJkcnNEM2MxYXVTZmNmZmFMVE1XS21nazktdWdDc3dvOEVzc2NiYUhFX3hnblJTcGo5ZXpWSWtDSUpoU081eTJFbzNRMnhfanBBOU1BMDRSZ0IxRV91MFZ0cU03VTZKR1NBc1RacDZzbHBfWlRlOW4?oc=5) - ScienceAlert• Creatine Is Having a Menopause Moment. Should It? (https://news.google.com/rss/articles/CBMitgFBVV95cUxOaDVNSl9Gc1pPd0JVckRXX1RqRXZpb0FrR3J4Sm1JcUpHWHZGdXhudV9CdU9Sd1MzYmJoeUlqQi14Z09CTC1FdmdFaHl4YnZDMjZnbWxtalEyNDM3T1RjZXZndXliN0RjYkxMekw5cUQ5Q0owMjhPYWpYbzF4Q251elVNd3RIeGRucFQySUw1eC13bFFOeERsUnlBT0dJS1FrQ0R5Ul85V3pQamF3QnprRmVnNjNudw?oc=5) - Flow Space• Processed foods, vegan diet, body weight, and severe hot flashes in postmenopausal women: secondary analysis of an RCT (https://pubmed.ncbi.nlm.nih.gov/42345553/) - Menopause (NAMS Journal)Listen with full show notes: https://hotflasher.com/episodes/2026-07-01-myth-bustingHave a menopause story to share? We'd love to hear it:https://hotflasher.com/share---Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
-
This episode goes deep on three symptom stories that don't get nearly enough airtime: the estrogen-dopamine link that may explain a flood of new ADHD diagnoses in perimenopause, the "esoteric" menopause symptoms that are common but almost never discussed, and a new NAMS-published study on how a soy-supplemented vegan diet affected hot flash severity — with some important caveats about what the findings actually mean.
Key Takeaways:
• Estrogen plays a direct role in dopamine regulation, which is why some women experience ADHD-like symptoms — or see existing ADHD dramatically worsen — during perimenopause and menopause.
• Many women with lifelong undiagnosed ADHD may have been partially compensating via estrogen, meaning the hormonal shift unmasks a condition that was always there rather than creating a new one.
• "Esoteric" menopause symptoms — things like electric shock sensations, itchy skin, tinnitus, and burning mouth — are common but rarely flagged by clinicians, leaving many women confused about the source.
• A secondary analysis published in the NAMS journal found that a soy-supplemented vegan diet was associated with significant weight loss and reduced severe hot flash frequency — but this was a secondary analysis of a randomized trial, not a primary endpoint study, which matters for how much weight you put on the findings.
• The processed-versus-unprocessed distinction didn't appear to drive the effect in the study — replacing animal foods with plant foods, regardless of processing level, was the factor associated with the outcome.
Sources & References:
• The curious connection between menopause and ADHD (https://news.google.com/rss/articles/CBMijwFBVV95cUxPZEU0dEdYemdRX01xM1FRMzZfc0FZMUhHdUt5cUpmeFRpbU12ckJZVlQ5MmM0cDhfMUxGWHd3MlhFSkM2cTM1MUpZeDNjYXZkSFZBdVVabkFydGFYY1k2SkgzNlpGTzduTDBnSzMzNXA1N3E0ZFFLOHBNYXBWRjBNSTlpcWVxRnQ1NnVVcjMtdw?oc=5) - Star Tribune
• Esoteric Symptoms of Menopause with Dr. Makeba Williams (https://audioboom.com/posts/8834264) - Dr. Streicher's Inside Information Podcast
• Processed foods, vegan diet, and severe hot flashes in postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42345553/) - Menopause (NAMS Journal)
Listen with full show notes: https://hotflasher.com/episodes/2026-06-30-symptom-spotlight
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns. -
This episode covers three research papers published in June and July 2026. Nykki looks at a simulation study proposing that menopause evolved as a solution to an even more brutal midlife energy problem, a clinical review calling out the gaps in sports medicine care for women across their lifespan, and a randomized trial on how to prevent the bone loss rebound that can happen when women stop taking denosumab.
Key Takeaways:
• A 2026 simulation study argues menopause may have evolved partly because the energy demands of simultaneously supporting older dependent children and aging parents made continued fertility unsustainable — and that stopping reproduction actually helped women survive that crunch.
• A new clinical review finds that female athletes are routinely underserved by sports medicine across their entire lifespan, with perimenopause and menopause largely absent from clinical protocols despite significant impacts on injury risk, recovery, and performance.
• Denosumab is a highly effective bone-density drug, but stopping it can trigger rapid bone loss — sometimes worse than baseline. A 2-year randomized trial published June 29, 2026 found that a single infusion of zoledronate at the time of stopping denosumab substantially prevented that rebound, in both women who had previously taken bisphosphonates and those who hadn't.
• The post-denosumab rebound risk is real enough that discontinuation should never happen without a transition plan — this is a conversation to have with your prescribing doctor before you stop.
• Sports medicine's failure to account for hormonal shifts across a woman's lifespan isn't just a gap in elite athletic care — it affects every active woman trying to stay injury-free in her 40s, 50s, and beyond.
Sources & References:
• Menopause averted a midlife energetic crisis: a simulation study (https://pubmed.ncbi.nlm.nih.gov/42366648/) - PubMed
• Female athletes through the lifespan: a call for comprehensive sports medicine care (https://pubmed.ncbi.nlm.nih.gov/42366521/) - PubMed
• Preventing post-denosumab bone loss with zoledronate: 2-year randomized trial (https://pubmed.ncbi.nlm.nih.gov/42366269/) - PubMed
Listen with full show notes: https://hotflasher.com/episodes/2026-06-29-research-roundup
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns. - Montre plus
